Levemir (insulin detemir) is now available in Malaysia in the form of Flexpen from September 2007 onwards.
Levemir is the latest generation of modern basal insulin of choice for both basal-bolus and basal+oral therapy, with up to 24 hour duration of action from a once-daily dose. Levemir provides compelling clinical advantages in terms of achieving glycaemic targets in HbA1 and FPG, lowering the risk of hypoglycaemic events and reducing weight gain. All of these benefits are built on the unique property of predictability that Levemir can deliver when used once daily or twice daily.
The Flexpen is trusted by more than 1.5 million people worldwide, and has emerged time and again, as the insulin delivery device of choice in various studies. The Flexpen is easy to use, hence most user friendly.
If you would like to get further information on Levemir or any assistance in using the device, please visit Nova Nordisk's website.
No comments:
Post a Comment